Literature DB >> 12362229

High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients.

Emmanuel Oger1, Luc Bressollette, Michel Nonent, Karine Lacut, Bruno Guias, Francis Couturaud, Christophe Leroyer, Dominique Mottier.   

Abstract

The prevention of venous thromboembolism in medical patients remains questioned. All consecutive outpatients admitted in our medical unit were considered for inclusion in this study which aimed to estimate the prevalence of asymptomatic venous thrombosis on admission and the incidence during hospital stay. Exclusion criteria were: age <18 years, suspicion of venous thromboembolism, stay <4 days, ongoing anticoagulant therapy. Venous compression ultrasonography of the lower limbs was performed within 48 h. 234 patients were included. The prevalence of asymptomatic deep vein thrombosis on admission and the incidence during hospital follow-up were respectively 5.5% (95% confidence interval, 3.1 to 9.5%) and 2.6 per 1,000 person-days (95% confidence interval, 0.0 to 5.2). The prevalence and the incidence reached respectively 17.8% (95% confidence interval, 8.5 to 32.6%) and 6.0 per 1,000 person-days (95% confidence interval, 0.0 to 12.7) among patients over 80 years. A high prevalence of asymptomatic deep vein thrombosis on admission was suggested particularly among elderly medical patients.

Entities:  

Mesh:

Year:  2002        PMID: 12362229

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

1.  Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis.

Authors:  Muhammad Ali; Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian
Journal:  Dig Dis Sci       Date:  2011-01-30       Impact factor: 3.199

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

Review 3.  Prevention of venous thromboembolism in medically ill patients: a clinical update.

Authors:  Alexander G G Turpie; Alain Leizorovicz
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

Review 4.  Standard or extended-duration prophylaxis in medical patients? A review of the evidence.

Authors:  J E Stark; W J Smith
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

Review 5.  Benefits versus risks of pharmacological prophylaxis to prevent symptomatic venous thromboembolism in unselected medical patients revisited. Meta-analysis of the medical literature.

Authors:  Moshe Vardi; Michal Steinberg; Michal Haran; Shai Cohen
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 6.  Current issues in thromboprophylaxis in the elderly.

Authors:  Parminder S Chaggar; Kevin S Channer
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Prevention and treatment of venous thromboembolism in the elderly patient.

Authors:  Enrico Tincani; Mark A Crowther; Fabrizio Turrini; Domenico Prisco
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

Review 8.  Primary prevention of venous thromboembolism in elderly medical patients.

Authors:  Karine Lacut; Gregoire Le Gal; Dominique Mottier
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

Review 9.  The association between air travel and deep vein thrombosis: systematic review & meta-analysis.

Authors:  Yaser Adi; Sue Bayliss; Andrew Rouse; R S Taylor
Journal:  BMC Cardiovasc Disord       Date:  2004-05-19       Impact factor: 2.298

10.  Prevalence of deep vein thrombosis in acutely admitted ambulatory non-surgical intensive care unit patients.

Authors:  Holger Lawall; Ralph Oberacker; Claudia Zemmrich; Peter Bramlage; Curt Diehm; Sebastian M Schellong
Journal:  BMC Res Notes       Date:  2014-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.